Virginie Marchand
- Molecular Biology top 2%
- Cancer Research top 2%
- Oncology
- Immunology
- Virology top 5%
- Co-authors
- Yuri MotorinMark HelmLilia AyadiAnne EphrussiFlorian PichotAdeline GalvaninDenis L. J. LafontaineChristiane Branlant
- Topics
- RNA modifications and cancer (75 papers)RNA and protein synthesis mechanisms (54 papers)Cancer-related molecular mechanisms research (31 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Virginie Marchand
99 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 2.5k
- Cancer Research 869
- Oncology 171
- Immunology 106
- Virology 103
Countries citing papers authored by Virginie Marchand
This map shows the geographic impact of Virginie Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Marchand more than expected).
Fields of papers citing papers by Virginie Marchand
This network shows the impact of papers produced by Virginie Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Marchand. The network helps show where Virginie Marchand may publish in the future.
Co-authorship network of co-authors of Virginie Marchand
This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Marchand. A scholar is included among the top collaborators of Virginie Marchand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Marchand. Virginie Marchand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 12 | |
| 11 | 4 | |
| 12 | 46 | |
| 13 | 32 | |
| 14 | 50 | |
| 15 | 37 | |
| 16 | 33 | |
| 17 | 36 | |
| 18 | 23 | |
| 19 | 46 | |
| 20 | 1 |
About Virginie Marchand
Virginie Marchand is a scholar working on Cancer Research, Molecular Biology and Virology, having authored 104 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (75 papers), RNA and protein synthesis mechanisms (54 papers) and Cancer-related molecular mechanisms research (31 papers). The work is most often cited by research in Cancer Research (869 citations), Molecular Biology (2.5k citations) and Virology (103 citations). Virginie Marchand has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Yuri Motorin, Mark Helm, Lilia Ayadi, Anne Ephrussi, Florian Pichot, Adeline Galvanin, Denis L. J. Lafontaine, Christiane Branlant, Valérie Bourguignon‐Igel and Imre Gáspár. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.